BHC insider trading
NYSE HealthcareBausch Health Companies Inc.: insider trade history from SEC Form 4 filings.
About Bausch Health Companies Inc.
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; dermatology products; generic pharmaceutical products; and dentistry products. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
Company website: www.bauschhealth.com
BHC insider activity at a glance
FilingIQ tracks 599 insider transactions for BHC in filings since Aug 13, 2018. The most recent transaction is dated Sep 30, 2026.
Across the full history, 38 open-market purchases
and 41 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on BHC insider trades is 58.3/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest BHC Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for BHC?
- FilingIQ tracks 599 Form 4 insider transactions for BHC (Bausch Health Companies Inc.), covering filings from Aug 13, 2018 onwards. 7 of those are dated within the last 90 days.
- Are BHC insiders net buyers or net sellers?
- Across the full Form 4 history for BHC, 38 transactions (6%) were open-market purchases and 41 (7%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does BHC insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is BHC in?
- Bausch Health Companies Inc. (BHC) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $1.86B.
Methodology & sources
Every BHC insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.